Earlier this year, Philips announced that it is collaborating with Sun Nuclear to integrate its suite of PlanIQ™ software into Pinnacle. At ASTRO, Philips is announcing that it has signed an agreement with Lifeline Software Inc. to utilize its dose verification technology. Lifeline is a developer of fully automated independent dosimetric validation calculations for conventional, IMRT, and VMAT treatment plans, including utilizing the ‘Monte Carlo’ dose calculation algorithm, widely recognized as the gold standard dose calculation method.
Visit Philips at booth #2111 at ASTRO. For more information about Philips’ presence at the show, including the full suite of Philips radiation oncology technology and integrated solutions, visit Philips’ ASTRO event website and follow @PhilipsLiveFrom for updates throughout #ASTRO18.
Ad Statistics
Times Displayed: 64511
Times Visited: 2110 Ampronix, a Top Master Distributor for Sony Medical, provides Sales, Service & Exchanges for Sony Surgical Displays, Printers, & More. Rely on Us for Expert Support Tailored to Your Needs. Email info@ampronix.com or Call 949-273-8000 for Premier Pricing.
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across th e health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2017 sales of EUR 17.8 billion and employs approximately 75,000 employees with sales and services in more than 100 countries. News about Philips can be found at http://www.philips.com/newscenter.
Back to HCB News
